References
- Ciliberti G, Seshasai SRK, Ambrosio G, et al. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. Int J Cardiol. 2017;244:77–83.
- Sueda S, Kohno H. Overview of complications during pharmacological spasm provocation tests. J Cardiol. 2016;68:1–6.
- Ahn JM, Lee KH, Yoo SY, et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol. 2016;68:137–145.
- Slavich M, Patel RS. Coronary artery spasm: current knowledge and residual uncertainties. Int J Cardiol Heart Vasc. 2016;10:47–53.
- Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019;0:1–71.
- JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013). Circ J. 2014;78:2779–2801.
- Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64:e139–e228.
- Sueda S, Miyoshi T, Sasaki Y, et al. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm. Heart Vessels. 2016;31:137–142.
- Shin DI, Baek SH, Her SH, et al. The 24-month prognosis of patients with positive or intermediate results in the intracoronary ergonovine provocation test. JACC Cardiovasc Interv. 2015;8:914–923.
- Isogai T, Yasunaga H, Matsui H, et al. Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in japan. Clin Cardiol. . 2015;38:171–177.
- Kim YG, Kim HJ, Choi WS, et al. Does a negative ergonovine provocation test truly predict freedom from variant angina? Korean Circ J. 2013;43:199–203.
- Zaya M, Mehta PK, Merz CN. Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol. 2014;63:103–109.
- Kim JH, Kim C, Kim J, et al. The effect of intracoronary administration of ergonovine on the contralateral coronary artery in a provocation test for the diagnosis of variant angina. Acta Cardiol. 2014;69:628–634.
- Takagi Y, Yasuda S, Takahashi J, et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: Multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2013;34:258–267.
- Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000;35:1850–1856.
- Suzuki Y, Tokunaga S, Ikeguchi S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J. 1992;124:39–47.
- Al Mheid I, Hayek S, Quyyumi AA. Provoking coronary vasospasm for diagnosis of variant angina: outdated trick of the trade or a resurgent diagnostic modality? JACC Cardiovasc Interv. 2015;8:924–926.
- Kobayashi T, Hirshfeld JW Jr. Radiation exposure in cardiac catheterization: operator behavior matters. Circ Cardiovasc Interv. 2017;10;e005689.